The Enterprise Value as of September 2024 (TTM) for Atara Biotherapeutics, Inc. (ATRA) is 113.52M

According to Atara Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 113.52M. This represents a change of -88.04% compared to the average of 949.30M of the last 4 quarters.

Atara Biotherapeutics, Inc. (ATRA) Historical Enterprise Value (quarterly & annually)

How has ATRA Enterprise Value performed in the past?

The mean historical Enterprise Value of Atara Biotherapeutics, Inc. over the last ten years is 7.39B. The current 113.52M Enterprise Value has changed 53.69% with respect to the historical average. Over the past ten years (40 quarters), ATRA's Enterprise Value was at its highest in in the September 2018 quarter at 18.41B. The Enterprise Value was at its lowest in in the September 2014 quarter at 124.52M.

Atara Biotherapeutics, Inc. (ATRA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Atara Biotherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Atara Biotherapeutics, Inc. (ATRA) Average Enterprise Value

How has ATRA Enterprise Value performed in the past?

The current Enterprise Value of Atara Biotherapeutics, Inc. (ATRA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Atara Biotherapeutics, Inc. (ATRA) Enterprise Value vs. Peers

How is ATRA’s Enterprise Value compared to its peers?

Atara Biotherapeutics, Inc.’s Enterprise Value is less than Fate Therapeutics, Inc. (521.43M), less than Sana Biotechnology, Inc. (954.19M), less than Caribou Biosciences, Inc. (181.03M), less than Arcus Biosciences, Inc. (1.50B), less than Heron Therapeutics, Inc. (443.95M), less than Allogene Therapeutics, Inc. (542.51M), greater than BioXcel Therapeutics, Inc. (75.06M), less than Karyopharm Therapeutics Inc. (206.10M), greater than X4 Pharmaceuticals, Inc. (50.65M), greater than HOOKIPA Pharma Inc. (95.66M), less than Mereo BioPharma Group plc (576.84M), greater than Galera Therapeutics, Inc. (-5856330.00), less than Acumen Pharmaceuticals, Inc. (116.47M), less than VectivBio Holding AG (848.58M), less than Icosavax, Inc. (713.87M), less than Apellis Pharmaceuticals, Inc. (4.69B), less than iTeos Therapeutics, Inc. (364.33M), less than TScan Therapeutics, Inc. (152.98M),

Build a custom stock screener for Atara Biotherapeutics, Inc. (ATRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atara Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atara Biotherapeutics, Inc. (ATRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atara Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.